International Atomic Energy Agency
Atlas of Non-FDG PET-CT in Diagnostic Oncology
Atlas of Non-FDG PET-CT in Diagnostic Oncology
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Couldn't load pickup availability
Excellent- More about Atlas of Non-FDG PET-CT in Diagnostic Oncology
Fluorodeoxyglucose (FDG) is a PET radiopharmaceutical used in oncology, but it has limitations in assessing certain tumors. To overcome this, non-FDG PET radiopharmaceuticals have been introduced, and PET/CT with these agents is part of personalized precision medicine. This publication provides a case-based approach to understanding normal biodistribution, variants, and pitfalls of these agents, with examples of typical patterns for different indications. It aims to facilitate accurate diagnosis and help professionals in non-FDG PET/CT imaging embrace the variety of oncological imaging.
Format: Paperback / softback
Length: 239 pages
Publication date: 30 December 2021
Publisher: IAEA
Fluorodeoxyglucose (FDG) is a radiopharmaceutical used in positron emission tomography (PET) imaging for oncology, offering significant benefits. However, it has limitations in assessing certain tumors, particularly prostate cancer. To address this, a trend has emerged of introducing non-FDG PET radiopharmaceuticals into clinical practice. PET/CT with tailored radiopharmaceuticals is part of personalized precision medicine, allowing for accurate assessment of tumor types and biologic processes. This publication aims to provide a case-based understanding of normal biodistribution, variants, and pitfalls of non-FDG PET radiopharmaceuticals. It includes examples of typical patterns for various indications, facilitating accurate image interpretation for accurate diagnosis. The Atlas serves as a valuable resource for professionals interested in non-FDG PET/CT imaging, offering clinically relevant teaching files on the effectiveness and diagnostic quality of non-FDG-PET/CT imaging in routine applications. By embracing the diversity of oncological imaging offered by non-FDG PET/CT, professionals can enhance their diagnostic capabilities and provide better care to patients.
Weight: 690g
Dimension: 297 x 210 (mm)
ISBN-13: 9789201289209
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
